108 related articles for article (PubMed ID: 9845322)
1. The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells.
Cardinale A; Lener M; Messina S; Cattaneo A; Biocca S
FEBS Lett; 1998 Nov; 439(3):197-202. PubMed ID: 9845322
[TBL] [Abstract][Full Text] [Related]
2. Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras.
Lener M; Horn IR; Cardinale A; Messina S; Nielsen UB; Rybak SM; Hoogenboom HR; Cattaneo A; Biocca S
Eur J Biochem; 2000 Feb; 267(4):1196-205. PubMed ID: 10672031
[TBL] [Abstract][Full Text] [Related]
3. Intracellular expression and functional properties of an anti-p21Ras scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains.
Cochet O; Kenigsberg M; Delumeau I; Duchesne M; Schweighoffer F; Tocqué B; Teillaud JL
Mol Immunol; 1998 Dec; 35(17):1097-110. PubMed ID: 10395199
[TBL] [Abstract][Full Text] [Related]
4. Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression.
Cochet O; Kenigsberg M; Delumeau I; Virone-Oddos A; Multon MC; Fridman WH; Schweighoffer F; Teillaud JL; Tocqué B
Cancer Res; 1998 Mar; 58(6):1170-6. PubMed ID: 9515802
[TBL] [Abstract][Full Text] [Related]
5. Aggresome formation by anti-Ras intracellular scFv fragments. The fate of the antigen-antibody complex.
Cardinale A; Filesi I; Biocca S
Eur J Biochem; 2001 Jan; 268(2):268-77. PubMed ID: 11168360
[TBL] [Abstract][Full Text] [Related]
6. Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy?
Cochet O; Gruel N; Fridman WH; Teillaud JL
Cancer Detect Prev; 1999; 23(6):506-10. PubMed ID: 10571661
[TBL] [Abstract][Full Text] [Related]
7. Use of living columns to select specific phage antibodies.
Bradbury A; Persic L; Werge T; Cattaneo A
Biotechnology (N Y); 1993 Dec; 11(13):1565-9. PubMed ID: 7694597
[TBL] [Abstract][Full Text] [Related]
8. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.
Yang JL; Liu DX; Zhen SJ; Zhou YG; Zhang DJ; Yang LY; Chen HB; Feng Q
BMC Cancer; 2016 Feb; 16():131. PubMed ID: 26897358
[TBL] [Abstract][Full Text] [Related]
9. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria.
Biocca S; Ruberti F; Tafani M; Pierandrei-Amaldi P; Cattaneo A
Biotechnology (N Y); 1995 Oct; 13(10):1110-5. PubMed ID: 9636285
[TBL] [Abstract][Full Text] [Related]
10. Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of xenopus oocytes.
Biocca S; Pierandrei-Amaldi P; Cattaneo A
Biochem Biophys Res Commun; 1993 Dec; 197(2):422-7. PubMed ID: 8267576
[TBL] [Abstract][Full Text] [Related]
11. Intracellular immunization with cytosolic recombinant antibodies.
Biocca S; Pierandrei-Amaldi P; Campioni N; Cattaneo A
Biotechnology (N Y); 1994 Apr; 12(4):396-9. PubMed ID: 7764686
[TBL] [Abstract][Full Text] [Related]
12. Activation of K-p21ras and N-p21ras, but not H-p21ras, is necessary for mitogen-induced human airway smooth-muscle proliferation.
Ammit AJ; Kane SA; Panettieri RA
Am J Respir Cell Mol Biol; 1999 Dec; 21(6):719-27. PubMed ID: 10572069
[TBL] [Abstract][Full Text] [Related]
13. The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300.
Pan XY; Liu XJ; Li J; Zhen SJ; Liu DX; Feng Q; Zhao WX; Luo Y; Zhang YL; Li HW; Yang JL
Gene Ther; 2017 Jan; 24(1):40-48. PubMed ID: 27834948
[TBL] [Abstract][Full Text] [Related]
14. A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites.
Werge TM; Bradbury A; Di Luzio A; Cattaneo A
Oncogene; 1992 May; 7(5):1033-5. PubMed ID: 1570149
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of ras GTPase activity by an anti-ras monoclonal antibody.
Agellon S; Stone JC
Mol Carcinog; 1996 Jul; 16(3):132-8. PubMed ID: 8688148
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of yeast adenylate cyclase by antibodies to ras p21.
Gibbs JB; Marsico-Ahern JD; Scolnick EM; Sigal IS
Biochem J; 1988 May; 252(1):289-92. PubMed ID: 2458712
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C-stimulated formation of ethanolamine from phosphatidylethanolamine involves a protein phosphorylation mechanism: negative regulation by p21 Ras protein.
Deli E; Kiss Z
Arch Biochem Biophys; 2000 May; 377(1):171-7. PubMed ID: 10775457
[TBL] [Abstract][Full Text] [Related]
18. Co-capping of ras proteins with surface immunoglobulins in B lymphocytes.
Graziadei L; Riabowol K; Bar-Sagi D
Nature; 1990 Sep; 347(6291):396-400. PubMed ID: 2120590
[TBL] [Abstract][Full Text] [Related]
19. Isolated limb perfusion based anti-p21ras gene therapy in a rat rhabdomyosarcoma.
Van Etten B; Van Tiel ST; Ambagtsheer G; Eggermont AM; Ten Hagen TL
Anticancer Res; 2004; 24(4):2295-301. PubMed ID: 15330175
[TBL] [Abstract][Full Text] [Related]
20. Evidence for proteasome dysfunction in cytotoxicity mediated by anti-Ras intracellular antibodies.
Cardinale A; Filesi I; Mattei S; Biocca S
Eur J Biochem; 2003 Aug; 270(16):3389-97. PubMed ID: 12899696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
